Genentech, a San Francisco-based biotech company, has decided to more than double its investment in a new drug manufacturing ...

An announcement from Anbio Biotechnology Class A ( ($NNNN) ) is now available. On December 30, 2025, Anbio Biotechnology reported unaudited ...

China quietly became biotech’s back-office, from molecule synthesis and clinical trials to novel drug licensing. Now the ...

Confirmed wild-type CFTR delivery and expression in conducting airway cells of patients with class I mutations KB407 transduction confirmed in all six patients with successful bronchoscopies irrespect ...

LIXTE Biotechnology Holdings (NASDAQ: LIXT) announced an expansion of its collaboration with The University of Texas MD Anderson Cancer Center and pharmaceutical manufacturer GSK on an ongoing ...

Detailed price information for Krystal Biotech Inc (KRYS-Q) from The Globe and Mail including charting and trades.

(RTTNews) - Insilico Medicine (3696.HK) has listed on the Hong Kong Stock Exchange, marking the latest biotech IPO in Hong Kong this year and becoming the first AI-driven biotech to go public on the ...

MITOLINE™ Algorithm Powers Development of First-in-Class Small Molecules Targeting a Mitochondrial Carrier for Inflammatory ...

Ultragenyx Pharmaceutical Inc. (NASDAQ:RARE) is one of the promising stocks to buy under $50. On January 8, Morgan Stanley ...

Kura Oncology holds a strong cash position with Komzifti FDA approval and frontline AML expansion potential. Read why KURA ...

Incyte (INCY) analysis: strong risk-adjusted returns, 20% YoY Q3 2025 revenue growth, diversification beyond Jakafi, and fair ...